军事知识服务平台
肺栓塞远期死亡危险因素及 Charlson合并症指数的预测价值
Risk factors associated with long-term mortality in patients with pulmonary embolism and the predictive value of Charlson comorbidity index
摘要 目的:调查肺栓塞患者的远期病死率,分析远期死亡的危险因素,并探讨Charlson合并症指数( CCI)在预测肺栓塞远期死亡中的价值。方法对2010年1月至2012年12月四川大学华西医院内科住院患者中确诊的234例肺栓塞患者中符合入选条件者随访观察至出院后2年。计算病死率,收集相关危险因素资料,经过单因素分析后,对可能有意义的因素再行多因素Logistic回归分析,寻找肺栓塞患者远期死亡的危险因素;以CCI量表对患者进行评分,通过生存分析探讨其对肺栓塞患者远期死亡的预测价值。结果最终入选176例肺栓塞患者,随访2年共有53例死亡,病死率为30.1%。单因素分析结果显示糖尿病( P=0.034)、恶性肿瘤( P=0.001)、慢性肺部疾病( P=0.035)、肝脏疾病(P=0.048)、长时间卧床(P=0.049)、不规范抗凝治疗(P=0.016)与肺栓塞患者远期死亡相关。多因素Logistic回归分析结果显示恶性肿瘤( OR=9.28,95%CI:2.85~31.00,P=0.003)、慢性肺部疾病(OR=2.96,95%CI:1.15~7.62,P=0.024)、不规范抗凝治疗(OR=4.08,95%CI:1.64~10.20,P=0.003)是肺栓塞患者远期死亡的独立危险因素。肺栓塞死亡组的CCI评分显著高于存活组[2(1,3)比1(0,2),P<0.001];有1个及以上伴随疾病的肺栓塞患者(CCI≥1分)的死亡风险是无伴随疾病患者(CCI=0分)的2.61倍(95%CI:1.14~6.00,P=0.024),而CCI评分每增加1分,肺栓塞患者的远期死亡风险便增加1.76倍(95%CI:1.04~2.97,P=0.035)。生存分析也表明,CCI≥1分肺栓塞患者2年累积生存率显著低于CCI=0分的患者(46.7%比78.5%,P=0.003)。结论恶性肿瘤、慢性肺部疾病、不规范抗凝治疗是内科肺栓塞患者远期死亡的独立危险因素;CCI在预测肺栓塞患者远期死亡中有一定价值,患者存在伴随疾病越多,死亡风险越高。
Abstract:
Objective To explore the risk factors associated with long-term mortality and the predictive value of Charlson comorbidity index ( CCI ) for long-term mortality in patients with pulmonary embolism ( PE).Methods A total of 234 patients with confirmed PE from the medical departments of West China Hospital of Sichuan University from January 2010 and December 2012 were enrolled, and these meeting the inclusion criteria were followed-up for 2 years after discharge.The long-term mortality was calculated and univariate and multivariate analysis were performed to identify the risk factors associated with long-term mortality of PE.All the patients were assessed the comorbidity burden with the CCI, and survival analysis was used to study its value in predicting long-term mortality in patients with PE.Results A total of 176 PE patients were finally included in this study, and 53 patients died during the follow-up period, with 2 years′mortality 30.1%.The univariate analysis showed diabetes (P=0.034), malignant neoplasm (P=0.001), chronic lung disease (P =0.035), liver disease (P=0.048), in bed for a long time (P =0.049), inappropriate anticoagulant therapy (P=0.016) were associated with the long-term mortality of PE patients.Among these risk factors, the multivariate analysis revealed malignant neoplasm ( OR =9.28,&nbsp;95%CI:2.85-31.00, P =0.003), chronic lung disease ( OR =2.96, 95%CI: 1.15 -7.62, P =0.024), inappropriate anticoagulant therapy (OR=4.08, 95%CI: 1.64 -10.20, P=0.003) were the independent risk factors.The median CCI scores for died PE patients during follow-up was higher than that for the survived PE patients ( ( 2 ( 1, 3 ) vs 1 ( 0, 2 ) , P <0.001 ); PE patients with one and more comorbidities (CCI≥1) were associated with 2.61-fold increased risk of long-term mortality compared with patients with no comorbidity (CCI=0) (95%CI:1.14-6.00, P=0.024).The per 1-score increase of CCI was associated with 1.76-fold increased risk of long-term mortality in PE patients ( 95%CI: 1.04 -2.97, P=0.035).Survival analysis showed that the 2-year cumulative survival of PE patients with CCI score≥1 was significant lower than that of patients with CCI =0 ( 46.7% vs 78.5%, P =0.003 ).Conclusions Malignant neoplasm, chronic lung disease and inappropriate anticoagulant therapy are independent risk factors of long-term mortality in patients with PE.The CCI can predict long-term mortality risk among patients with PE and the risk increases with the increase of comorbidites patients have.
Author: Zhou Haixia Tang Yongjiang Wang Lan Shi Chaoli Feng Yulin Yi Qun
作者单位: 四川大学华西医院呼吸与危重症医学科, 成都,610041
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2016, 96(4)
机标分类号: R65 R54
在线出版日期: 2016年4月22日
基金项目: (2011BA11B17):国家科技支撑计划,